Citations

Mayo Clinic

Showing 10 of 108572 citations.

SCLEROMYXEDEMA WITH RETINAL VASCULITIS AND MACULAR EDEMA
Gutiérrez-Aguirre, Karen I., Stewart, Michael W., Sluzevich, Jason C. , Sluzevich, Jason C

RETINAL Cases & Brief Reports | June 26, 2016 | Volume: 11 | Issue: 4 | Pages: 319-322

10.1097/icb.0000000000000353 | PMID 27348792 Get It

Background/Purpose: To describe the findings and clinical course of a patient with scleromyxedema complicated by retinal vasculitis and macular edema. Methods: Interventional case report. Results: A 64-year old Caucasian woman with recently diagnosed, biopsy proven scleromyxedema presented with decreased visual acuity (20/50 OD; 20/100 OS) due to retinal vasculitis and macular edema. She received intravitreal bevacizumab and subtenon's triamcinolone acetonide for the macular edema, and bilateral pars plana vitrectomies were required for vitreous hemorrhages. Monthly intravenous infusions of immunoglobulins (IVIG) resulted in resolution of the macular edema and vasculitis, and stabilization of the VA (20/40 OD; counting fingers at 6 feet OS). Conclusion: Scleromyxedema may be complicated by retinal vasculitis and macular edema. Treatment with corticosteroids and vascular endothelial growth factor inhibitors may be minimally effective but IVIG should be considered for both the ocular and systemic findings.
A 72-Year-Old End-Stage Liver Disease Patient With Lethargy
López‐Chiriboga, A. Sebastian , Snipelisky, David , Arosemena, Marilyn , Almeida, N. De, Bhide, Vandana, Brumble, Lisa , Lopez-Chiriboga, A Sebastian

Infectious Diseases in Clinical Practice | June 26, 2016 | Volume: 24 | Issue: 4 | Pages: 241-242

10.1097/ipc.0000000000000405 Get It

Sedation Variability Increases Incidence of Delirium in Adult Medical Intensive Care Unit Patients at a Tertiary Academic Medical Center
Ritchie, Brianne M., Torbic, Heather , DeGrado, Jeremy R. , Reardon, David P.

American Journal of Therapeutics | June 25, 2016 | Volume: 26 | Issue: 1 | Pages: e92-e95

10.1097/mjt.0000000000000455 | PMID 27340907 Get It

Background: Variability in sedation may increase the incidence of delirium and mortality, as well as increased intensive care unit (ICU) and hospital lengths of stay (LOS), despite mean Richmond Agitation Sedation Scale (RASS) scores at goal. Coefficient of variation (CV) can be used to represent variability with a higher ratio indicating increased variability. Study Question: Do patients with an increased variability in sedation, as evaluated by CV in RASS, have an increased incidence of delirium? Methods: We conducted a retrospective chart review of adult medical ICU patients requiring mechanical ventilation (MV) for ≥24 hours between January and April 2013. Patients were excluded if intubated at an outside hospital, neuromuscularly blocked, suffering from anoxic brain injury, or had a goal RASS of −4 or −5. Outcomes assessed included the presence of delirium, as evaluated by the Confusion Assessment Method, RASS, CV in RASS, duration of MV, ICU, and hospital LOS, and survival. Results: Of 45 included patients, 32 experienced delirium during their ICU admission and 13 did not. The groups were similar at baseline. There was no difference in mean RASS when comparing the delirium and nondelirium groups (−1.6 ± 1.3 vs. −1.8 ± 0.8, respectively; P = 0.61). Patients with delirium had a greater CV in RASS (0.3 ± 0.135 vs. 0.2 ± 0.105; P = 0.02), a longer MV duration [4 (2–8) vs. 3 (2–3) days; P = 0.045], and a trend toward increased ICU LOS [8 (5–12.25) vs. 4 (3–8) days; P = 0.096], but no difference in hospital LOS [13 (10–25) vs. 18 (9–39) days; P = 0.83] and survival (71.9% vs. 69.2%; P = 1.0). Conclusion: Medical ICU patients with delirium had a higher CV in RASS compared with patients without delirium, suggesting that greater variability in sedation may increase the incidence of delirium. Patients with delirium also had a greater duration of MV and a trend toward longer ICU LOS.
Is Gianotti–Crosti Syndrome Associated with Atopy? A Case–Control Study and a Postulation on the Intrinsic Host Factors in Gianotti–Crosti Syndrome
Chuh, Antonio , Zawar, Vijay , Sciallis, Gabriel F., Sciallis, Gabriel, Lee, Albert

Pediatric Dermatology | June 25, 2016 | Volume: 33 | Issue: 5 | Pages: 488-492

10.1111/pde.12886 | PMID 27339179 Get It

AbstractObjectivesTo investigate whether Gianotti–Crosti syndrome (GCS) in children is associated with atopy.MethodsThe setting was two outpatient clinic. Diagnoses of asthma and atopic dermatitis (AD) were made according to internationally accepted diagnostic criteria. Allergic rhinitis, atopic urticaria, and allergic conjunctivitis were diagnosed clinically. Participants were children with GCS diagnosed over the previous 5 years. For any child with GCS, we extracted the record of the subsequent age and sex pair‐matched child seen for problems unrelated to the skin as controls.ResultsWe retrieved the records of 37 pairs of study and control subjects; 28 (76%) children with GCS and 9 (24%) controls had AD (risk ratio [RR] = 3.11[95% confidence interval {CI} 1.73, 5.73]), 31 (84%) children with GCS and 19 (51%) controls had at least one atopic condition (RR = 1.63 [95% CI 1.13, 2.18]) and 11 (30%) children with GCS and 2 (5%) controls had at least three atopic conditions (RR = 5.50 [95% CI 1.29, 35.35]).ConclusionGCS is significantly associated with AD and the presence of atopic conditions.
Expression profiling and ontology analysis of circulating long non-coding RNAs in septic acute kidney injury patients
Huang, Chunmei , Ge, Qinmin , Shuming, Pan, Zhu, Xiangyang , Shu-Ming, Pan

Clinical Chemistry and Laboratory Medicine (CCLM) | June 25, 2016 | Volume: 54 | Issue: 12 | Pages: e395-e399

10.1515/cclm-2015-1281 | PMID 27341563 Get It

A pharmacogenetic analysis of the Canadian Cancer Trials Group MY.10 clinical trial of maintenance therapy for multiple myeloma
Han, Ming , Murugesan, Alli , Song, Kevin , White, Darrell , Chen, Christine , Seftel, Matthew D. , Howsen-Jan, Kang, Reece, Donna , Stewart, Keith, Xie, Ya‐Gang, Hay, Annette E. , Shepherd, Lois E. , Djurfeldt, Marina, Zhu, Liting , Meyer, Ralph M., Chen, Bingshu E. , Reiman, Tony , Bahlis, Nizar Jacques , Chen, Bingshu E

Blood | June 25, 2016 | Volume: 128 | Issue: 5 | Pages: 732-735

10.1182/blood-2016-06-716902 | PMID 27338095 Get It

Creatinine–Based and Cystatin C–Based GFR Estimating Equations and Their Non-GFR Determinants in Kidney Transplant Recipients
Keddis, Mira T. , Amer, Hatem , Voskoboev, Nikolay, Kremers, Walter K. , Rule, Andrew D. , Lieske, John C. , Amer, Hatem , Kremers, Walter K

Clinical Journal of the American Society of Nephrology | June 25, 2016 | Volume: 11 | Issue: 9 | Pages: 1640-1649

10.2215/cjn.11741115 | PMID 27340283 Get It

Background and objectives eGFR equations have been evaluated in kidney transplant recipients with variable performance. We assessed the performance of the Modification of Diet in Renal Disease equation and the Chronic Kidney Disease Epidemiology Collaboration equations on the basis of creatinine, cystatin C, and both (eGFR creatinine-cystatin C) compared with measured GFR by iothalamate clearance and evaluated their non-GFR determinants and associations across 15 cardiovascular risk factors. Design, setting, participants, & measurements A cross-sectional cohort of 1139 kidney transplant recipients >1 year after transplant was analyzed. eGFR bias, precision, and accuracy (percentage of estimates within 30% of measured GFR) were assessed. Interaction of each cardiovascular risk factor with eGFR relative to measured GFR was determined. Results Median measured GFR was 55.0 ml/min per 1.73 m 2 . eGFR creatinine overestimated measured GFR by 3.1% (percentage of estimates within 30% of measured GFR of 80.4%), and eGFR Modification of Diet in Renal Disease underestimated measured GFR by 2.2% (percentage of estimates within 30% of measured GFR of 80.4%). eGFR cystatin C underestimated measured GFR by −13.7% (percentage of estimates within 30% of measured GFR of 77.1%), and eGFR creatinine-cystatin C underestimated measured GFR by −8.1% (percentage of estimates within 30% of measured GFR of 86.5%). Lower measured GFR associated with older age, women, obesity, longer time after transplant, lower HDL, lower hemoglobin, lower albumin, higher triglycerides, higher proteinuria, and an elevated cardiac troponin T level but did not associate with diabetes, smoking, cardiovascular events, pretransplant dialysis, or hemoglobin A1c. These risk factor associations differed for five risk factors with eGFR creatinine, six risk factors for eGFR Modification of Diet in Renal Disease, ten risk factors for eGFR cystatin C, and four risk factors for eGFR creatinine-cystatin C. Conclusions Thus, eGFR creatinine and eGFR creatinine-cystatin C are preferred over eGFR cystatin C in kidney transplant recipients because they are less biased, more accurate, and more consistently reflect the same risk factor associations seen with measured GFR.
The prognostic impact of bone marrow fibrosis in primary myelofibrosis
Elliott, Michelle A. , Tefferi, Ayalew

American Journal of Hematology | June 25, 2016 | Volume: 91 | Issue: 10 | Pages: No page available

10.1002/ajh.24458 | PMID 27342701 Get It

Closure of a Recurrent Bronchopleural Fistula Using a Matrix Seeded With Patient-Derived Mesenchymal Stem Cells
Aho, Johnathon M. , Dietz, Allan B. , Radel, Darcie J., Butler, Greg W., Thomas, Mathew , Carlsen, Brian T. , Cassivi, Stephen D. , Resch, Zachary T., Faubion, William A. , Wigle, Dennis A. , Nelson, Timothy J. , Thomas, Mathew , Dietz, Allan B

Stem Cells Translational Medicine | June 25, 2016 | Volume: 5 | Issue: 10 | Pages: 1375-1379

10.5966/sctm.2016-0078 | PMID 27343169 Get It

Abstract Management of recurrent bronchopleural fistula (BPF) after pneumonectomy remains a challenge. Although a variety of devices and techniques have been described, definitive management usually involves closure of the fistula tract through surgical intervention. Standard surgical approaches for BPF incur significant morbidity and mortality and are not reliably or uniformly successful. We describe the first-in-human application of an autologous mesenchymal stem cell (MSC)-seeded matrix graft to repair a multiply recurrent postpneumonectomy BPF. Adipose-derived MSCs were isolated from patient abdominal adipose tissue, expanded, and seeded onto bio-absorbable mesh, which was surgically implanted at the site of BPF. Clinical follow-up and postprocedural radiological and bronchoscopic imaging were performed to ensure BPF closure, and in vitro stemness characterization of patient-specific MSCs was performed. The patient remained clinically asymptomatic without evidence of recurrence on bronchoscopy at 3 months, computed tomographic imaging at 16 months, and clinical follow-up of 1.5 years. There is no evidence of malignant degeneration of MSC populations in situ, and the patient-derived MSCs were capable of differentiating into adipocytes, chondrocytes, and osteocytes using established protocols. Isolation and expansion of autologous MSCs derived from patients in a malnourished, deconditioned state is possible. Successful closure and safety data for this approach suggest the potential for an expanded study of the role of autologous MSCs in regenerative surgical applications for BPF. Significance Bronchopleural fistula is a severe complication of pulmonary resection. Current management is not reliably successful. This work describes the first-in-human application of an autologous mesenchymal stem cell (MSC)-seeded matrix graft to the repair of a large, multiply recurrent postpneumonectomy BPF. Clinical follow-up of 1.5 years without recurrence suggests initial safety and feasibility of this approach. Further assessment of MSC grafts in these difficult clinical scenarios requires expanded study.
Semiautomated Segmentation of Polycystic Kidneys in T2-Weighted MR Images
Kline, Timothy L. , Edwards, Marie E., Korfiatis, Panagiotis , Akkus, Zeynettin , Torres, Vicente E. , Erickson, Bradley J. , Torres, Vicente E , Akkus, Zeynettin

American Journal of Roentgenology | June 24, 2016 | Volume: 207 | Issue: 3 | Pages: 605-613

10.2214/ajr.15.15875 | PMID 27341140 Get It